375
Participants
Start Date
January 11, 2021
Primary Completion Date
September 1, 2026
Study Completion Date
September 1, 2030
Pertuzumab+TRASTUZUMAB
Trastuzumab + pertuzumab SC FDC (PHESGO) will be administered on Day 1 of each 21-day cycle , subcutaneous, fixed dose
ADJUVANT ENDOCRINE THERAPY
Oral, daily per cycle
RECRUITING
New York University Langone Health, New York
RECRUITING
New York University Langone Hospital -Brooklyn, Brooklyn
RECRUITING
New York University Langone Hospital - Long Island, Mineola
RECRUITING
UNC Rex Hematology Oncology Associated - Cary, Cary
RECRUITING
UNC Rex Hematology Oncology Associates of Garner, Garner
RECRUITING
University of North Carolina at Chapel Hill, Chapel Hill
RECRUITING
UNC Rex Cancer Center, Raleigh
RECRUITING
UNC Rex Cancer Center at Wakefield, Raleigh
RECRUITING
Winship Cancer Institute at Emory University Hospital Midtown, Atlanta
RECRUITING
Emory University - Winship Cancer Institute, Atlanta
RECRUITING
Winship Cancer Institute at Emory Saint Joseph's Hospital, Atlanta
RECRUITING
University of Miami- Sylvester Comprehensive Cancer Center, Miami
RECRUITING
Sarah Cannon Research Institute/Tennessee Oncology, Nashville
RECRUITING
SCRI Oncology Partners, Nashville
RECRUITING
Vanderbilt University Medical Center, Nashville
RECRUITING
Ohio State University Comprehensive Cancer Center, Columbus
RECRUITING
The Christ Hospital, Cincinnati
RECRUITING
Indiana University Health Schwarz Cancer Center, Indianapolis
RECRUITING
Indiana University Health - Melvin and Bren Simon Cancer Center, Indianapolis
RECRUITING
Indiana University Sidney and Lois Eskenazi Hospital, Indianapolis
RECRUITING
University of Chicago Medical Center, Chicago
RECRUITING
Baylor College of Medicine Medical Center, Houston
RECRUITING
MD Anderson Cancer Center, Houston
RECRUITING
Stamford Hospital, Stamford
RECRUITING
Eastern Maine Medical Center (Northern Light), Brewer
RECRUITING
Dana Farber Cancer Institite, Boston
RECRUITING
Beth Israel Deaconess Medical Center, Boston
RECRUITING
Dana-Farber Brigham Cancer Center - Foxborough, Foxborough
RECRUITING
Cape Cod Healthcare Center, Hyannis
RECRUITING
Dana-Farber at Milford, Milford
RECRUITING
Dana-Farber at South Shore Hospital, Weymouth
RECRUITING
Dana-Farber Cancer Insitute at Londonderry Hospital, Londonderry
Collaborators (1)
Genentech, Inc.
INDUSTRY
Dana-Farber Cancer Institute
OTHER